411 related articles for article (PubMed ID: 12721334)
1. Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy?
Zeilhofer HU; Calò G
J Pharmacol Exp Ther; 2003 Aug; 306(2):423-9. PubMed ID: 12721334
[TBL] [Abstract][Full Text] [Related]
2. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
3. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
Zhang Y; Simpson-Durand CD; Standifer KM
Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
[TBL] [Abstract][Full Text] [Related]
4. Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences.
Rizzi A; Nazzaro C; Marzola GG; Zucchini S; Trapella C; Guerrini R; Zeilhofer HU; Regoli D; Calo' G
Pain; 2006 Sep; 124(1-2):100-8. PubMed ID: 16697109
[TBL] [Abstract][Full Text] [Related]
5. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.
Calo G; Guerrini R; Rizzi A; Salvadori S; Burmeister M; Kapusta DR; Lambert DG; Regoli D
CNS Drug Rev; 2005; 11(2):97-112. PubMed ID: 16007234
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
Gavioli EC; Calo' G
Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
[TBL] [Abstract][Full Text] [Related]
7. Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development.
Wtorek K; Janecka A
Chem Biodivers; 2021 Jan; 18(1):e2000871. PubMed ID: 33351271
[TBL] [Abstract][Full Text] [Related]
8. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
Meunier JC
Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
[TBL] [Abstract][Full Text] [Related]
9. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.
Thompson AA; Liu W; Chun E; Katritch V; Wu H; Vardy E; Huang XP; Trapella C; Guerrini R; Calo G; Roth BL; Cherezov V; Stevens RC
Nature; 2012 May; 485(7398):395-9. PubMed ID: 22596163
[TBL] [Abstract][Full Text] [Related]
10. Changes in expression of nociceptin/orphanin FQ and its receptor in spinal dorsal horn during electroacupuncture treatment for peripheral inflammatory pain in rats.
Fu X; Wang YQ; Wang J; Yu J; Wu GC
Peptides; 2007 Jun; 28(6):1220-8. PubMed ID: 17493706
[TBL] [Abstract][Full Text] [Related]
11. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
Chiou LC; Fan SH; Chuang KC; Liao YY; Lee SZ
Ann N Y Acad Sci; 2004 Oct; 1025():398-403. PubMed ID: 15542742
[TBL] [Abstract][Full Text] [Related]
14. [Nociceptin/orphanin FQ (N/OFQ)--the opioid, antiopioid or neuromodulator?].
Kotlińska J; Rafalski P
Postepy Hig Med Dosw (Online); 2004 Apr; 58():209-15. PubMed ID: 15114256
[TBL] [Abstract][Full Text] [Related]
15. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
[TBL] [Abstract][Full Text] [Related]
16. Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders.
Ubaldi M; Cannella N; Borruto AM; Petrella M; Micioni Di Bonaventura MV; Soverchia L; Stopponi S; Weiss F; Cifani C; Ciccocioppo R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884757
[TBL] [Abstract][Full Text] [Related]
17. Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor.
Depner UB; Reinscheid RK; Takeshima H; Brune K; Zeilhofer HU
Eur J Neurosci; 2003 Jun; 17(11):2381-7. PubMed ID: 12814369
[TBL] [Abstract][Full Text] [Related]
18. Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux.
D'Agostino B; Marrocco G; De Nardo M; Calò G; Guerrini R; Gallelli L; Advenier C; Rossi F
Br J Pharmacol; 2005 Mar; 144(6):813-20. PubMed ID: 15685213
[TBL] [Abstract][Full Text] [Related]
19. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.
Donica CL; Awwad HO; Thakker DR; Standifer KM
Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957
[TBL] [Abstract][Full Text] [Related]
20. The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury.
Okuda-Ashitaka E; Minami T; Matsumura S; Takeshima H; Reinscheid RK; Civelli O; Ito S
Eur J Neurosci; 2006 Feb; 23(4):995-1004. PubMed ID: 16519664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]